PDA is pleased to announce the results of the 2017 Board of Directors election.
Directors
Congratulations to the following Directors elected by PDA’s membership to the board:
- Barbara M.
Allen, PhD,
Senior Director,
Global Quality
Systems, Eli Lilly
& Company, looks forward to
shaping “the future to meet the
needs of each of the members.”
- Joyce
Bloomfield
sees this as her
opportunity to
continue doing “all
that I can do to lead
the advancement of medicine
and manufacturing technology in
order to facilitate availability of
medicine to patients everywhere.”
- Véronique
Davoust,
PharmD,
Senior Manager,
Global Quality
Intelligence, Pfizer,
wants to contribute “even more
actively to the success of PDA
by enhancing PDA’s activities
in influencing regulations in the
Quality/GMP arena.”
- Ghada Haddad,
Director, Global
Quality Risk
Management
Center of Excellence,
Merck, plans to
“devote greater service to the PDA
and its members by working
to ensure quality, accuracy and
relevance to the technical reports,
the programs and training events.”
Outgoing Directors
PDA would also like to thank the following outgoing Directors for their service on the board:
- Glenn Wright, Senior Director, Project
Management TS/MS, Eli Lilly and Company
- John Shabushnig, PhD, Principal Consultant,
Insight Pharma Consulting